Enhancing Dengue Virus Production and Immunogenicity with CelcradleTM Bioreactor: A Comparative Study with Traditional Cell Culture Methods
Hongxia Guo,Xiaoyan Ding,Dong Hua,Minchi Liu,Maocheng Yang,Yuanxin Gong,Nan Ye,Xiaozhong Chen,Jiuxiang He,Yu Zhang,Xiaofeng Xu,Jintao Li
DOI: https://doi.org/10.3390/vaccines12060563
2024-05-22
Vaccines
Abstract:The dengue virus, the primary cause of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome, is the most widespread mosquito-borne virus worldwide. In recent decades, the prevalence of dengue fever has increased markedly, presenting substantial public health challenges. Consequently, the development of an efficacious vaccine against dengue remains a critical goal for mitigating its spread. Our research utilized CelcradleTM, an innovative tidal bioreactor optimized for high-density cell cultures, to grow Vero cells for dengue virus production. By maintaining optimal pH levels (7.0 to 7.4) and glucose concentrations (1.5 g/L to 3.5 g/L) during the proliferation of cells and viruses, we achieved a peak Vero cell count of approximately 2.46 × 109, nearly ten times the initial count. The use of CelcradleTM substantially decreased the time required for cell yield and virus production compared to conventional Petri dish methods. Moreover, our evaluation of the immunogenicity of the CelcradleTM-produced inactivated DENV4 through immunization of mice revealed that sera from these mice demonstrated cross-reactivity with DENV4 cultured in Petri dishes and showed elevated antibody titers compared to those from mice immunized with virus from Petri dishes. These results indicate that the dengue virus cultivated using the CelcradleTM system exhibited enhanced immunogenicity relative to that produced in traditional methods. In conclusion, our study highlights the potential of the CelcradleTM bioreactor for large-scale production of inactivated dengue virus vaccines, offering significant promise for reducing the global impact of dengue virus infections and accelerating the development of effective vaccination strategies.
immunology,medicine, research & experimental